Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more
Market Cap & Net Worth: Indoco Remedies Limited (INDOCO)
Indoco Remedies Limited (NSE:INDOCO) has a market capitalization of $212.85 Million (₹18.43 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #18951 globally and #921 in its home market, demonstrating a 1.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indoco Remedies Limited's stock price ₹200.01 by its total outstanding shares 92161805 (92.16 Million).
Indoco Remedies Limited Market Cap History: 2015 to 2026
Indoco Remedies Limited's market capitalization history from 2015 to 2026. Data shows change from $335.50 Million to $212.85 Million (-4.20% CAGR).
Index Memberships
Indoco Remedies Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$69.23 Billion | 0.12% | #189 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.01% | #633 of 750 |
Weight: Indoco Remedies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Indoco Remedies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Indoco Remedies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Indoco Remedies Limited's market cap is 0.01 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $268.77 Million | $10.04 Billion | $829.80 Million | 0.03x | 0.32x |
| 2017 | $291.57 Million | $10.97 Billion | $770.61 Million | 0.03x | 0.38x |
| 2018 | $226.19 Million | $10.18 Billion | $411.61 Million | 0.02x | 0.55x |
| 2019 | $200.49 Million | $9.42 Billion | -$29.04 Million | 0.02x | N/A |
| 2020 | $318.59 Million | $10.80 Billion | $241.17 Million | 0.03x | 1.32x |
| 2021 | $477.52 Million | $12.19 Billion | $930.46 Million | 0.04x | 0.51x |
| 2022 | $428.32 Million | $15.04 Billion | $1.55 Billion | 0.03x | 0.28x |
| 2023 | $418.86 Million | $16.40 Billion | $1.42 Billion | 0.03x | 0.29x |
| 2024 | $353.52 Million | $17.88 Billion | $984.60 Million | 0.02x | 0.36x |
| 2025 | $249.66 Million | $16.65 Billion | -$737.40 Million | 0.01x | N/A |
Competitor Companies of INDOCO by Market Capitalization
Companies near Indoco Remedies Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Indoco Remedies Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Indoco Remedies Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Indoco Remedies Limited's market cap moved from $335.50 Million to $ 212.85 Million, with a yearly change of -4.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹212.85 Million | -14.74% |
| 2025 | ₹249.66 Million | -29.38% |
| 2024 | ₹353.52 Million | -15.60% |
| 2023 | ₹418.86 Million | -2.21% |
| 2022 | ₹428.32 Million | -10.30% |
| 2021 | ₹477.52 Million | +49.89% |
| 2020 | ₹318.59 Million | +58.90% |
| 2019 | ₹200.49 Million | -11.36% |
| 2018 | ₹226.19 Million | -22.42% |
| 2017 | ₹291.57 Million | +8.48% |
| 2016 | ₹268.77 Million | -19.89% |
| 2015 | ₹335.50 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Indoco Remedies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $212.85 Million USD |
| MoneyControl | $212.85 Million USD |
| MarketWatch | $212.85 Million USD |
| marketcap.company | $212.85 Million USD |
| Reuters | $212.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.